PBS updates

Tertroxin (Liothyronine)

liothyronine sodium 20 microgram tablet, 100 · ORAL · PBS code 2318B

STREAMLINED

What it costs

AU$41.19 PBS-determined price per 100 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

  • • First listed on the PBS: 1991-08-01.
  • • Repeats: 2.
  • • PBS program: GE.
Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Thyroid cancer


Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) a nurse practitioner who is continuing treatment with this medicine (of any strength) that was initiated by a medical practitioner as a PBS benefit.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Hypothyroidism


The treatment must be for replacement therapy; AND

Patient must have documented intolerance to levothyroxine sodium; or

Patient must have documented resistance to levothyroxine sodium; AND

Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) a nurse practitioner who is continuing treatment with this medicine (of any strength) that was initiated by a medical practitioner as a PBS benefit.

Sponsor: Aspen Pharmacare Australia Pty Limited ABN 51 096 236 985

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.